----
Q2 FY2026 EarningsQ2 FY26 revenue of $55.2M was in-line with consensus ($55.4M), despite a 9% YoY decline. Profitability exceeded expectations, with Adjusted EBITDA of $14.6M and Adjusted Net Income of $7.5M beating the $5.9M consensus. Management provided Q3 revenue guidance of $54.0M–$55.0M, slightly below the previous run-rate, but FY26 guidance remains disciplined with an Adjusted EBITDA margin outlook of 26%–27%.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Definitive Healthcare(DH) the Revenue is 55.2 M (-9.14%), Miss estimate;the EBIT is 11.84 M (-24.29%), Beat estimate;the EPS is -0.05 (+28.57%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.06B9.14%
0.06B8.83%
-0.00B0.31%
EBITExceed expectations
0.01B24.29%
0.01B28.77%
+0.00B4.48%
EPSExceed expectations
-0.0528.57%
-0.078512.20%
+0.028540.77%
Upcoming earnings report - Q3 FY2026
Available dateNov 12, 2026
Estimate Revenue$54.57 M
Estimate EBIT$11.11 M
Estimate EPS-$0.0565
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly
